In this study, a new drug carrier based on gelled-oil
nanoparticles
(GNPs) was designed and synthesized for the encapsulation and release
of the model hydrophobic drug, berberine chloride (BCl). Two compositions
with different oil phases were examined, sesame oil (SO) and cinnamaldehyde
(Cin), which were emulsified with water, stabilized with Tween 80
(Tw80), and gelled using an N-alkylated primary oxalamide low-molecular-weight
gelator (LMWG) to give stable dispersions of GNPs between 100 and
200 nm in size. The GNP formulation with Cin was significantly favored
over SO due to (1) lower gel melting temperatures, (2) higher gel
mechanical strength, and (3) significantly higher solubility, encapsulation
efficiency, and loading of BCl. Also, the solubility and loading of
BCl in Cin were significantly increased (at least 7-fold) with the
addition of cinnamic acid. In vitro release studies showed that the
release of BCl from the GNPs was independent of gelator concentration
and lower than that for BCl solution and the corresponding nanoemulsion
(no LWMG). Also, cell internalization studies suggested that the N-alkylated
primary oxalamide LMWG did not interfere with the internalization
efficiency of BCl into mouse mast cells. Altogether, this work demonstrates
the potential use of these new GNP formulations for biomedical studies
involving the encapsulation of drugs and nutraceuticals and their
controlled release.